Hudson Bay Capital Management’s Gilead Sciences GILD Stock Holding History

Hudson Bay Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-315,000	Closed	-$35M	–	1318
2025 Q3	$35M	Buy	315,000 +28,600	+10%	+$3.25M	0.12%	149
2025 Q2	$31.8M	Buy	286,400 +21,500	+8%	+$2.29M	0.11%	151
2025 Q1	$29.7M	Buy	264,900 +154,900	+141%	+$16M	0.09%	196
2024 Q4	$10.2M	Hold	110,000	–	–	0.04%	364
2024 Q3	$9.22M	Buy	+110,000	New	+$8.39M	0.04%	305
2018 Q3	–	Sell	-36,100	Closed	-$2.56M	–	771
2018 Q2	$2.56M	Buy	36,100 +16,100	+81%	+$1.14M	0.04%	451
2018 Q1	$1.51M	Buy	+20,000	New	+$1.59M	0.03%	500
2017 Q2	–	Sell	-20,000	Closed	-$1.36M	–	633
2017 Q1	$1.36M	Sell	20,000 -10,000	-33%	-$703K	0.02%	558
2016 Q4	$2.15M	Buy	+30,000	New	+$2.23M	0.04%	334
2016 Q3	–	Sell	-55,000	Closed	-$4.59M	–	466
2016 Q2	$4.59M	Buy	+55,000	New	+$4.88M	0.14%	109

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Hudson Bay Capital Management's GILD Position: Q1 2026 in Review

Hudson Bay Capital Management reduced its Gilead Sciences (GILD) stake by 27% in Q1 2026, selling an estimated $5.16M and leaving 100,010 shares worth $13.9M. The position accounts for 0.05% of the portfolio, ranked #247.

Hudson Bay Capital Management first reported a position in GILD in Q2 2014 and has held it in 24 quarters since. The position peaked at $34.7M in Q1 2024. 2,315 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

Hudson Bay Capital Management held 100,010 shares of Gilead Sciences worth $13.9M as of Q1 2026.
Hudson Bay Capital Management sold 36,861 Gilead Sciences shares in Q1 2026, an estimated $5.16M.
Gilead Sciences made up 0.05% of Hudson Bay Capital Management's portfolio in Q1 2026, its #247 holding.
Hudson Bay Capital Management first reported a position in Gilead Sciences in Q2 2014 and has held it in 24 quarters since.
Hudson Bay Capital Management's Gilead Sciences position peaked at $34.7M in Q1 2024.
2,315 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.